Similar companies
Income Statement (NONE)
| Q3 '25 | QoQ | |
|---|---|---|
| Revenue | 1.05B | 2.5% |
| Gross Profit | 639M | 10.8% |
| Cost of Revenue | 410M | 8.2% |
| Operating expense | 402M | 24.9% |
| Net Income | 187M | 3.9% |
| EBITDA | 347M | 3.9% |
Balance Sheet (NONE)
| Q3 '25 | QoQ | |
|---|---|---|
| Total Assets | 8.81B | 0% |
| Total Liabilities | 3.96B | 0% |
| Total Equity | 4.84B | 0% |
| Shares Outstanding | 226M | 0.1% |
Cash Flow (NONE)
| Q3 '25 | QoQ |
|---|
EPS
Financial Highlights for Hologic in Q3 '25
Hologic reported a revenue of 1.05B, which is a 2.5% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 639M, marking a 10.8% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 410M, a -8.2% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 402M, showing a 24.9% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was 187M, showing a -3.9% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 347M, showing a 3.9% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Hologic faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies.
